| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767067 | SERONO | Follicle stimulating hormone and pharmaceutical compositions containing same |
Jun, 2015
(8 years ago) | |
Fertinex is owned by Serono.
Fertinex contains Urofollitropin.
Fertinex has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Fertinex are:
- US5767067
Fertinex was authorised for market use on 18 September, 1986.
Fertinex is available in injectable;subcutaneous dosage forms.
The generics of Fertinex are possible to be released after 16 June, 2015.
Drugs and Companies using UROFOLLITROPIN ingredient
Market Authorisation Date: 18 September, 1986
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
FERTINEX family patents
